Log in to save to my catalogue

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B:...

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B:...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808642415

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

About this item

Full title

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

Publisher

England: BMJ Publishing Group LTD

Journal title

Gut, 2015-08, Vol.64 (8), p.1289-1295

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

BackgroundHepatocellular carcinoma (HCC) risk-scores may predict HCC in Asian entecavir (ETV)-treated patients. We aimed to study risk factors and performance of risk scores during ETV treatment in an ethnically diverse Western population.MethodsWe studied all HBV monoinfected patients treated with ETV from 11 European referral centres within the V...

Alternative Titles

Full title

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1808642415

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808642415

Other Identifiers

ISSN

0017-5749

E-ISSN

1468-3288

DOI

10.1136/gutjnl-2014-307023

How to access this item